Theralase Technologies Inc
XTSX:TLT
Theralase Technologies Inc
XTSX:TLT
Price:
0.265
CAD
-1.85%
Market Cap:
CA$68.1m
Wall Street
Price Targets
TLT Price Targets Summary
Theralase Technologies Inc
Theralase Technologies Inc
Wall Street analysts forecast TLT stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
TLT
is 0.714 CAD
with a low forecast of 0.707 CAD and a high forecast of 0.735 CAD.
Lowest
Price Target
0.707
CAD
167% Upside
Average
Price Target
0.714
CAD
169% Upside
Highest
Price Target
0.735
CAD
177% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TLT's stock price target?
Price Target
0.714
CAD
0.714
CAD
According to Wall Street analysts, the average 1-year price target for
TLT
is 0.714 CAD
with a low forecast of 0.707 CAD and a high forecast of 0.735 CAD.
What is Theralase Technologies Inc's Revenue forecast?
Projected CAGR
223%
223%
For the last 13 years the
compound annual growth rate for
Theralase Technologies Inc's revenue is
-5%.
The projected
CAGR
for the next 3 years is
223%.
